The Effect of Turmeric on New Onset Primary Dysmenorrhea

The study was planned as 150 patients. Patients who met early-onset dysmenorrhea criteria and who met the inclusion criteria; 150 patients were divided into 2 equal groups, and NSAID during the menstrual cycle, nsai + turmeric 1 gr oral powder form treatment was planned to be started in the other group. The pain frequency and severity before and after treatment were evaluated by visual analog scale and the two groups were compared.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Primary Dysmenorrhea

Age range

16 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Batman Maternity and Child's health Hospital

Batman, 72000, Turkey (Türkiye)

About this study

There are scientific publications on the use of turmeric, which constitutes the hypothesis of our study, in branches such as cardiology, neurology, infertility and chest diseases due to its anti-inflammatory, anti-aging properties.

The data are planned to be evaluated by the researchers using the SPSS(Statistical Package for the Social Sciences ) 17.0 program on computer. The responses of all groups to the VAS scores are planned to be entered into the system by using the SPSS program before and after treatment. statistics (number, percentage, mean, standard deviation), chi-square and logistic regression analysis are used to compare categorical variables. Chi-square test and Mann Whitney-U test are planned to be used in comparison between groups.When examining the difference between the groups, if the p value is less than 0.05, it is planned as a proof of significant difference.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Early-onset primary dysmenorrhea (Definition: Pain that begins in less than 6 months, is not accompanied by infection, begins on the first day of menstruation and ends on the last day of menstruation)
Non-pregnant and breastfeeding patients
Between 16-35 years old
No anatomic pathology or disease
Lack of active infection
No history of drug use
BMI is less than 25
Those who wish to participate in the study signed the consent form
Smoking, non-alcoholic patients
Patients who completed their treatment and came to the control
Regular menstruation

Exclusion criteria

Presence of vaginal infection such as Trichomonas vaginalis and candida albicans
Patients who do not want to participate in the study
Pregnant and nursing patients
Be under 16 years or older than 30 years
Systemic disease
Smoking, alcohol consumption
BMI higher than 25
People with organic pelvic pathology (ovarian cyst, fibroids, polyps)
People with a history of drug use
Patients who discontinue treatment and do not come to control
Irregular menstruation
Any history of contraindication to naproxen
Turmeric allergy history

Treatment and study plan

Naproxen

Drug

use of naproxen twice a day orally in mens time

Other names: NSAI(nonsteroidal anti-inflammatory agent)

Turmeric

Dietary Supplement

Use of turmeric orally (1 gram powder formula) in mens time

Primary outcomes

the effect of turmeric on visual analog scala at new onset primary dysmenorrhea

Time frame: 6 months

To determine the effect of turmeric use on pain severity in early onset primary .The minimum pain score for dysmenorrhea is defined as 1 maximal pain score of 10 and a significant difference is planned if there is a significant difference between pretreatment scores and post-treatment scores if at least 50 percent reduction in turmeric use is achieved.It is predicted that there is no significant difference in visual analog scale scoring less than 50 percent and treatment is not effective.

Before and after the treatment of turmeric effect on visual analog scores will be compared and a significant difference will be observed if at least 50 percent improvement is detected.dysmenorrhea using visual analogue scoring.

The percentage of reduction in visual analog scores will be calculated in all patients using turmeric.

Sponsors and collaborators

Lead sponsor

Batman Training and Research Hospital

Other Gov

Registry information

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Dec 3, 2019
Registry last updated: Apr 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed